Work

Cost-Utility Analysis of Dapagliflozin Versus Saxagliptin Treatment as Monotherapy or Combination Therapy as Add-on to Metformin for Treating Type 2 Diabetes Mellitus

Year: 2020

Type: article

Source: Applied Health Economics and Health Policy

DOI: 10.1007/s40258-020-00603-7

Authors: Shanshan Hu, Xun Deng, Yanjiao Ma, Zhilei Li, Yuhang Wang, Yong Wang

Institutions: Zhujiang Hospital, Southern Medical University

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Natural Science Foundation of China

Award: G3150512018

OpenAlex ID: W3048595070

FWCI: 2.125

Cites: 43

Cited by: 18

Related to: 10